Leukemias Ppt
-
Upload
ancy-varkey -
Category
Documents
-
view
223 -
download
0
Transcript of Leukemias Ppt
8/11/2019 Leukemias Ppt
http://slidepdf.com/reader/full/leukemias-ppt 1/15
LEUKEMI S
Normal human blood
White Cell Red Cell
Platelet
Blood with leukemia
BlastsRed Cell
Platelet
White Cell
8/11/2019 Leukemias Ppt
http://slidepdf.com/reader/full/leukemias-ppt 2/15
DEVELOPMENT OF LEUKEMIA
IN THE BLOODSTREAM
Stage 1- Normal Stage 2- Symptoms Stage 3- Diagnosis
Stage 4- Worsening
Stage 5a- Anemia
Stage 5b- Infection
Legend
White Cell
Red Cell
PlateletBlast
Germ Sources from Leukemia, by D. Newton and D. Siegel
8/11/2019 Leukemias Ppt
http://slidepdf.com/reader/full/leukemias-ppt 3/15
1. ACUTE MYELOID LEUKEMIA
(AML)
It results from a defect inthe hematopoetic stem
cell that differentiatesinto all myeloid cells – monocytes, granulocytes( neutrophils, basophils,
eosinophils )erythrocytes andplatelets.
8/11/2019 Leukemias Ppt
http://slidepdf.com/reader/full/leukemias-ppt 4/15
Cont….
8/11/2019 Leukemias Ppt
http://slidepdf.com/reader/full/leukemias-ppt 5/15
CLINICAL MANIFESTATION
Fever and infectionfrom neutropenia
Bleeding tendencies
from thrombocytopenia Weakness and fatigue
from anemia
Pain from enlarged liver
or spleen Hyperplasia of gums
Bone pain fromexpansion of marrow
8/11/2019 Leukemias Ppt
http://slidepdf.com/reader/full/leukemias-ppt 6/15
MEDICAL MANAGEMENT
INDUCTION THERAPY:Involves high doses of
Cytarabine ( cytosar) and Daunarubicin(cerubidin) or Idarubicin (idamycin) to eradicate
the leukemic cells.
CONSOLIDATION THERAPY (post remission) :
For this, multiple
treatment cycles of various agents are used ,usually containing some form of cytarabine ( eg.Cytosar, ara-c) frequently, patient receives onecycle of treatment at a lower dosage resulting inless toxicity.
8/11/2019 Leukemias Ppt
http://slidepdf.com/reader/full/leukemias-ppt 7/15
Cont….
Supportive careincludes –
Administering
blood products(PRBCs and platelets)and promptly treating
infections.
BMT
8/11/2019 Leukemias Ppt
http://slidepdf.com/reader/full/leukemias-ppt 8/15
2. CHRONIC MYELOID
LEUKEMIA
CML originate in thepluripotent stem cell or it arisesfrom a mutation in the myeloidstem cell.
Normal myeloid cells continueto be produced , but then ispathologic increase in theproduction of forms of blastcells. Therefore a widespectrum of cell types existswithin the blood, from blastforms through mature
neutrophils.
8/11/2019 Leukemias Ppt
http://slidepdf.com/reader/full/leukemias-ppt 9/15
CLINICAL MANIFESTATIONS
CBC –Leukocyte count greaterthan 100,000/mm
Short of breath or slightly confuseddue to decrease capillaryperfusion to the lungs and brainfrom leukostasis.
Enlarged tender spleen
Sometimes malaise, anorexia ,weight loss.
8/11/2019 Leukemias Ppt
http://slidepdf.com/reader/full/leukemias-ppt 10/15
MANAGEMENT
Treatment is usually divided into 4 areas:
1. Stem cell transplantation
2. Interferon alpha therapy with or without
chemotherapy
3. Single agent chemotherapy ( hydroxyurea)
4. The use of specific Tyrosine kinase
inhibitors
8/11/2019 Leukemias Ppt
http://slidepdf.com/reader/full/leukemias-ppt 11/15
Cont…..
8/11/2019 Leukemias Ppt
http://slidepdf.com/reader/full/leukemias-ppt 12/15
Cont…..
The goal of therapy in the chronic phase is tocontrol leukocytosis and thrombocytosis.
8/11/2019 Leukemias Ppt
http://slidepdf.com/reader/full/leukemias-ppt 13/15
APHERESIS
LEUKAPHERESISSPLENECTOMY
8/11/2019 Leukemias Ppt
http://slidepdf.com/reader/full/leukemias-ppt 14/15
Cont….
Most widely used medicationsare interferon alphaadministered IV or SC andhydroxyurea administeredorally.
Clients with blast crisis requireintensive chemotherapy withsame agent as in acuteleukemia
Targeted therapy: Imatinibmesylate ( Gleevec) inhibitsproliferation
8/11/2019 Leukemias Ppt
http://slidepdf.com/reader/full/leukemias-ppt 15/15
Thank you